Baker Chad R Pfizer Inc Transaction History

Baker Chad R

$496 Million
Q3 2024

A detailed history of Baker Chad R transactions in Pfizer Inc stock. As of the latest transaction made, Baker Chad R holds 24,500 shares of PFE stock, worth $628,425. This represents 0.14% of its overall portfolio holdings.

Number of Shares

24,500

Previous 24,500 -0.0%

Holding current value

$628,425

Previous $685,000 3.5%

% of portfolio

0.14%

Previous 0.15%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $861,839 - $976,320	-24,000 Reduced 49.48%	24,500 $959,000
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $1.27 Million - $1.82 Million	-47,000 Reduced 49.21%	48,500 $1.58 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $634,601 - $723,514	-16,496 Reduced 14.73%	95,500 $4.17 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $239,104 - $254,909	-7,250 Reduced 6.08%	111,996 $4.06 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $3.66 Million - $3.88 Million	-110,000 Reduced 47.98%	119,246 $4.32 Million
Q2 2017 Aug 14, 2017	BUY	N/A	229,246	229,246 $7.7 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Chad R, based on Form 13F filings with the SEC.

News

Stay updated on Baker Chad R with notifications on news.

Account